But analysis of T-ALL cases overexpressing NKX2-3 did not show enhanced NFATC2 levels (GSE26713), excluding involvement of this factor in aberrant NKX2-3 regulation. The gene discussed is NFATC2; the disease is acute lymphoblastic leukemia.